BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 12353679)

  • 1. The use of topical fluorouracil to treat actinic keratosis.
    Robins P; Gupta AK
    Cutis; 2002 Aug; 70(2 Suppl):4-7. PubMed ID: 12353679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation.
    Gupta AK
    Cutis; 2002 Aug; 70(2 Suppl):30-6. PubMed ID: 12353678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-week treatment with once-daily fluorouracil cream 0.5% in participants with actinic keratoses.
    Menter A; Vamvakias G; Jorizzo J
    Cutis; 2008 Jun; 81(6):509-16. PubMed ID: 18666394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of actinic keratosis with 0.5% fluorouracil cream for 1, 2, or 4 weeks.
    Weiss J; Menter A; Hevia O; Jones T; Ling M; Rist T; Roberts J; Shavin JS; Sklar J; Webster G; Connolly M; Furst K; Levy S
    Cutis; 2002 Aug; 70(2 Suppl):22-9. PubMed ID: 12353677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorouracil 5% and 0.5% creams for the treatment of actinic keratosis: equivalent efficacy with a lower concentration and more convenient dosing schedule.
    Jorizzo JL; Carney PS; Ko WT; Robins P; Weinkle SH; Werschler WP
    Cutis; 2004 Dec; 74(6 Suppl):18-23. PubMed ID: 15666898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.
    Jorizzo J; Stewart D; Bucko A; Davis SA; Espy P; Hino P; Rodriguez D; Savin R; Stough D; Furst K; Connolly M; Levy S
    Cutis; 2002 Dec; 70(6):335-9. PubMed ID: 12502122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Efficacy of Topical Fluorouracil Cream, 5%, for Treating Actinic Keratosis: A Randomized Clinical Trial.
    Pomerantz H; Hogan D; Eilers D; Swetter SM; Chen SC; Jacob SE; Warshaw EM; Stricklin G; Dellavalle RP; Sidhu-Malik N; Konnikov N; Werth VP; Keri J; Lew R; Weinstock MA;
    JAMA Dermatol; 2015 Sep; 151(9):952-60. PubMed ID: 25950503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
    Ulrich M; Alarcon I; Malvehy J; Puig S
    Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis.
    Loven K; Stein L; Furst K; Levy S
    Clin Ther; 2002 Jun; 24(6):990-1000. PubMed ID: 12117087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel 0.5% fluorouracil cream is minimally absorbed into the systemic circulation yet is as effective as 5% fluorouracil cream.
    Levy S; Furst K; Chern W
    Cutis; 2002 Aug; 70(2 Suppl):14-21. PubMed ID: 12353676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment.
    Kaur RR; Alikhan A; Maibach HI
    J Dermatolog Treat; 2010 Sep; 21(5):267-71. PubMed ID: 19878034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical photodynamic therapy of actinic keratosis in renal transplant recipients.
    Piaserico S; Belloni Fortina A; Rigotti P; Rossi B; Baldan N; Alaibac M; Marchini F
    Transplant Proc; 2007; 39(6):1847-50. PubMed ID: 17692630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results.
    Stockfleth E; Kerl H; Zwingers T; Willers C
    Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study.
    Jorizzo J; Weiss J; Vamvakias G
    J Drugs Dermatol; 2006 Feb; 5(2):133-9. PubMed ID: 16485881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options in the management of actinic keratosis.
    Jorizzo JL; Carney PS; Ko WT; Robins P; Weinkle SH; Werschler WP
    Cutis; 2004 Dec; 74(6 Suppl):9-17. PubMed ID: 15666897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment.
    Jury CS; Ramraka-Jones VS; Gudi V; Herd RM
    Br J Dermatol; 2005 Oct; 153(4):808-10. PubMed ID: 16181465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
    Smith SR; Morhenn VB; Piacquadio DJ
    J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
    Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
    Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.